CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,218 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03424382
NCT03424382N/ACompleted

CREATION Health Readmission Risk Assessment Tool

AdventHealth·observational·Posted Feb 7, 2018·Updated Feb 7, 2020

In Brief

An observational study for Heart Failure and 7 related conditions. Completed, enrolled 1,218 participants across 1 site.

Detailed Summary

This study occurs in two phases. Phase 1 involves initial item development and measurement validation of a new tool for identifying hospitalized patients at high risk for preventable readmission. Primary tasks include item construction and content validation, data collection, analysis, and instrument refinement. Phase 2 involves administering the refined instrument to a new group of patients to determine final item content for the instrument, its factor structure, and its predictive validity.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 7, 2018
Enrollment StartMay 15, 2017
Primary CompletionDec 5, 2018
Study CompletionNov 26, 2019
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 8.4 years ago